These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 36344983)
1. Comprehensive clinical evaluation of TomoEQA for patient-specific pre-treatment quality assurance in helical tomotherapy. Kim C; Han MC; Lee YK; Shin HB; Kim H; Kim JS Radiat Oncol; 2022 Nov; 17(1):177. PubMed ID: 36344983 [TBL] [Abstract][Full Text] [Related]
2. TomoEQA: Dose verification for patient-specific quality assurance in helical tomotherapy using an exit detector. Han MC; Chang KH; Kim J; Han SC; Park K; Kim DW; Kim H; Kim JS Phys Med; 2021 Feb; 82():1-6. PubMed ID: 33508632 [TBL] [Abstract][Full Text] [Related]
3. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation. Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942 [TBL] [Abstract][Full Text] [Related]
4. Clinical implementation of Dosimetry Check™ for TomoTherapy Chung E; Kwon D; Park T; Kang H; Chung Y J Appl Clin Med Phys; 2018 Nov; 19(6):193-199. PubMed ID: 30354001 [TBL] [Abstract][Full Text] [Related]
5. A method to reconstruct and apply 3D primary fluence for treatment delivery verification. Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913 [TBL] [Abstract][Full Text] [Related]
6. Clinical implementation of an exit detector-based dose reconstruction tool for helical tomotherapy delivery quality assurance. Deshpande S; Xing A; Metcalfe P; Holloway L; Vial P; Geurts M Med Phys; 2017 Oct; 44(10):5457-5466. PubMed ID: 28737014 [TBL] [Abstract][Full Text] [Related]
7. Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method. Bresciani S; Di Dia A; Maggio A; Cutaia C; Miranti A; Infusino E; Stasi M Med Phys; 2013 Dec; 40(12):121711. PubMed ID: 24320497 [TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report. Fusella M; Cavinato S; Germani A; Paiusco M; Pivato N; Rossato MA; Scott A; Scaggion A Radiat Oncol; 2021 Nov; 16(1):226. PubMed ID: 34809645 [TBL] [Abstract][Full Text] [Related]
9. In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data. Schopfer M; Bochud FO; Bourhis J; Moeckli R Med Phys; 2019 May; 46(5):1963-1971. PubMed ID: 30810233 [TBL] [Abstract][Full Text] [Related]
10. Statistical analysis of correlation of gamma passing results for two quality assurance phantoms used for patient-specific quality assurance in volumetric modulated arc radiotherapy. Kunii Y; Tanabe Y; Nakamoto A; Nishioka K Med Dosim; 2022 Winter; 47(4):329-333. PubMed ID: 35850758 [TBL] [Abstract][Full Text] [Related]
11. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. Zhen H; Nelms BE; Tome WA Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366 [TBL] [Abstract][Full Text] [Related]
12. A diagnostic tool for basic daily quality assurance of a Tomotherapy Hi*Art machine. de Vondel IV; Tournel K; Verellen D; Duchateau M; Lelie S; Storme G J Appl Clin Med Phys; 2009 Oct; 10(4):151-164. PubMed ID: 19918225 [TBL] [Abstract][Full Text] [Related]
13. Initial clinical experience with ArcCHECK for IMRT/VMAT QA. Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107 [TBL] [Abstract][Full Text] [Related]
14. Detection of dose delivery variations on TomoTherapy using on-board detector based verification. Hui C; Chen Q; Khandelwal S; Neal B; Watkins W Phys Med Biol; 2018 Jul; 63(14):14NT02. PubMed ID: 29938689 [TBL] [Abstract][Full Text] [Related]